TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Philippe Guardiola, Catherine Lacombe et al.|Blood|2009Cited by 270
Concurrent <i>CDX2 cis</i>-deregulation and <i>UBTF::ATXN7L3</i> fusion define a novel high-risk subtype of B-cell ALLMarie Passet, Emmanuelle Clappier, Rathana Kim et al.|Blood|2022Cited by 34
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 <sup>+</sup> Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic LeukemiaJean‐Baptiste Robin, Thibaut Leguay, Marc Delord et al.|Journal of Clinical Oncology|2024Cited by 33
Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i> -Mutant Clonal HematopoiesisRathana Kim, Emmanuelle Clappier, Hugo Bergugnat et al.|Blood Cancer Discovery|2023Cited by 33
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemiaNicolas Duployez, Claude Preudhomme, Loïc Vasseur et al.|Leukemia|2023Cited by 30